Glycomics/Glycobiology Market (By Product: Reagents, Kits, Enzymes, Instruments; By Application: Diagnostics, Drug Discovery & Development, Others; By End Use: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, CROs) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Glycomics/Glycobiology
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Glycomics/Glycobiology Market By Product
1.2.2.1. Global Glycomics/Glycobiology Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Glycomics/Glycobiology Market Revenue Share By Product in 2017
1.2.2.3. Reagents
1.2.2.4. Kits
1.2.2.5. Enzymes
1.2.2.6. Instruments
1.2.3. Glycomics/Glycobiology Market By Application
1.2.3.1. Global Glycomics/Glycobiology Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.3.2. Diagnostics
1.2.3.3. Drug Discovery & Development
1.2.3.4. Others
1.2.4. Glycomics/Glycobiology Market By End Use
1.2.4.1. Global Glycomics/Glycobiology Market Revenue and Growth Rate Comparison By End Use (2015-2026)
1.2.4.2. Pharmaceutical & Biotechnology Companies
1.2.4.3. Academic & Research Institutes
1.2.4.4. CROs
1.2.5. Glycomics/Glycobiology Market by Geography
1.2.5.1. Global Glycomics/Glycobiology Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Glycomics/Glycobiology Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Glycomics/Glycobiology Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Glycomics/Glycobiology Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Glycomics/Glycobiology Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Glycomics/Glycobiology Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Glycomics/Glycobiology Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Glycomics/Glycobiology Major Manufacturers in 2017
3.3. R&D Status and Technology Product of Global Glycomics/Glycobiology Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Glycomics/Glycobiology Major Manufacturers in 2017

CHAPTER 4. GLYCOMICS/GLYCOBIOLOGY MARKET BY PRODUCT

4.1. Global Glycomics/Glycobiology Revenue By Product
4.2. Reagents
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Kits
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Enzymes
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Instruments
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. GLYCOMICS/GLYCOBIOLOGY MARKET BY APPLICATION

5.1. Global Glycomics/Glycobiology Revenue By Application
5.2. Diagnostics
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Drug Discovery & Development
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. GLYCOMICS/GLYCOBIOLOGY MARKET BY END USE

6.1. Global Glycomics/Glycobiology Revenue By End Use
6.2. Pharmaceutical & Biotechnology Companies
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Academic & Research Institutes
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

7.1. North America Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Glycomics/Glycobiology Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

8.1. Europe Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

9.1. Asia-Pacific Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

10.1. Latin America Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

11.1. Middle East Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA GLYCOMICS/GLYCOBIOLOGY MARKET BY COUNTRY

12.1. Africa Glycomics/Glycobiology Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Glycomics/Glycobiology Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Use, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Agilent Technologies
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Thermo Fisher Scientific, Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Takara Bio, Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Merck KGaA
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Bruker
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Shimadzu Corporation
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Biolabs
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Danaher
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. ProZyme
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope